Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jibo Han

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Basic Research in Cardiology|October 2, 2023
Novel GSDMD inhibitor GI-Y1 protects heart against pyroptosis and ischemia/reperfusion injury by blocking pyroptotic pore formationLingfeng Zhong, Jibo Han, Xiaoxi Fan, et al.
Molecular Medicine (Cambridge, Mass.)|April 9, 2026
PARP7 alleviates lipopolysaccharide-induced acute kidney injury by inhibiting TBK1-driven inflammation in renal tubular epithelial cellsJiajun Xu, Huihui Xie, Zhouyang Zhu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 6, 2023
Emodin attenuates cardiomyocyte pyroptosis in doxorubicin-induced cardiotoxicity by directly binding to GSDMDShanshan Dai, Yunxuan Chen, Xiaoxi Fan, et al.
Circulation Research|February 1, 2023
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in CardiomyocytesBozhi Ye, Hao Zhou, Yanghao Chen, et al.
Nature Communications|July 2, 2025
Cardiomyocyte-derived USP13 protects hearts from hypertrophy via deubiquitinating and stabilizing STAT1 in male miceJibo Han, Liming Lin, Zimin Fang, et al.
American Journal of Physiology. Cell Physiology|December 18, 2023
OTUD6A in tubular epithelial cells mediates angiotensin II-induced kidney injury by targeting STAT3Xiaoyu Sun, Shuhong Chen, Ying Zhao, et al.
Theranostics|October 21, 2024
Cardiomyocyte-derived USP28 negatively regulates antioxidant response and promotes cardiac hypertrophy via deubiquitinating TRIM21Jibo Han, Liming Lin, Zimin Fang, et al.
International Immunopharmacology|January 23, 2024
Macrophage-derived GSDMD promotes abdominal aortic aneurysm and aortic smooth muscle cells pyroptosisBozhi Ye, Xiaoxi Fan, Zimin Fang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 2, 2024
Macrophage-Derived GSDMD Plays an Essential Role in Atherosclerosis and Cross Talk Between Macrophages via the Mitochondria-STING-IRF3/NF-κB AxisXiaoxi Fan, Jibo Han, Lingfeng Zhong, et al.
Clinical and Translational Medicine|March 5, 2025
The novel GSDMD inhibitor GI-Y2 exerts antipyroptotic effects to reduce atherosclerosisXiaoxi Fan, Zhenfeng Cheng, Ruiyin Shao, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Basic Research in Cardiology|October 2, 2023
Novel GSDMD inhibitor GI-Y1 protects heart against pyroptosis and ischemia/reperfusion injury by blocking pyroptotic pore formationLingfeng Zhong, Jibo Han, Xiaoxi Fan, et al.
Molecular Medicine (Cambridge, Mass.)|April 9, 2026
PARP7 alleviates lipopolysaccharide-induced acute kidney injury by inhibiting TBK1-driven inflammation in renal tubular epithelial cellsJiajun Xu, Huihui Xie, Zhouyang Zhu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 6, 2023
Emodin attenuates cardiomyocyte pyroptosis in doxorubicin-induced cardiotoxicity by directly binding to GSDMDShanshan Dai, Yunxuan Chen, Xiaoxi Fan, et al.
Circulation Research|February 1, 2023
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in CardiomyocytesBozhi Ye, Hao Zhou, Yanghao Chen, et al.
Nature Communications|July 2, 2025
Cardiomyocyte-derived USP13 protects hearts from hypertrophy via deubiquitinating and stabilizing STAT1 in male miceJibo Han, Liming Lin, Zimin Fang, et al.
American Journal of Physiology. Cell Physiology|December 18, 2023
OTUD6A in tubular epithelial cells mediates angiotensin II-induced kidney injury by targeting STAT3Xiaoyu Sun, Shuhong Chen, Ying Zhao, et al.
Theranostics|October 21, 2024
Cardiomyocyte-derived USP28 negatively regulates antioxidant response and promotes cardiac hypertrophy via deubiquitinating TRIM21Jibo Han, Liming Lin, Zimin Fang, et al.
International Immunopharmacology|January 23, 2024
Macrophage-derived GSDMD promotes abdominal aortic aneurysm and aortic smooth muscle cells pyroptosisBozhi Ye, Xiaoxi Fan, Zimin Fang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 2, 2024
Macrophage-Derived GSDMD Plays an Essential Role in Atherosclerosis and Cross Talk Between Macrophages via the Mitochondria-STING-IRF3/NF-κB AxisXiaoxi Fan, Jibo Han, Lingfeng Zhong, et al.
Clinical and Translational Medicine|March 5, 2025
The novel GSDMD inhibitor GI-Y2 exerts antipyroptotic effects to reduce atherosclerosisXiaoxi Fan, Zhenfeng Cheng, Ruiyin Shao, et al.
Pageof 7